Tuesday 29 September 2015 7:23 am Roche breast cancer drug wins approval for use in UK By: Sarah Spickernell Add as a preferred source on Google NULL
Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights Business Wire
Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets Business Wire
Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™ Business Wire